SS Innovations 任命 Sarah M. Romano 為新任財務總監，8月3日生效

EX-99.1
3
ea029760101ex99-1.htm
PRESS RELEASE, DATED JULY 14, 2026

 

Exhibit 99.1

 

 

SS Innovations Appoints Sarah M. Romano as Chief
Financial Officer

 

Veteran medtech finance executive brings extensive
public company and capital markets experience to support the Company’s next phase of global growth

 

Fort Lauderdale, FL – July 14, 2026
– SS Innovations International, Inc. (the “Company” or “SS
Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable
and accessible to a global population, today announced the appointment of Sarah M. Romano as Chief Financial Officer, effective August
3, 2026. Ms. Romano will be based in the United States.

 

Dr. Sudhir Srivastava, Chairman of the Board and
Chief Executive Officer of SS Innovations, commented, “We are thrilled to welcome Sarah as our Chief Financial Officer at this critical
moment in our growth journey. As we continue our global expansion, including pursuing U.S. FDA approval of our advanced, cost-effective
SSi Mantra surgical robotic system, Sarah brings strong financial leadership, keen strategic vision, and extensive capital markets experience.
She will play an integral role in scaling and enhancing our financial operations to accommodate our anticipated growth.”

 

Ms. Romano added, “I am delighted for this
opportunity to collaborate closely with Dr. Sudhir and the leadership team as SS Innovations delivers on its mission to democratize global
access to cutting-edge surgical robotic care.”

 

Ms. Romano is a seasoned public company finance
executive, bringing more than two decades of experience leading capital strategy, corporate growth, and financial operations in the medical
technology and life sciences industries. Most recently, Ms. Romano served as Chief Financial Officer of Vicarious Surgical, a robotic
surgery company where she led financial and operational initiatives to significantly reduce cash burn, strengthen the balance sheet, and
support the company’s strategic objectives. Previously, she served as Chief Financial Officer of Entero Therapeutics and Kiora Pharmaceuticals,
where she led capital raising activities, strategic transactions, SEC reporting, and investor relations programs. Throughout her career,
Ms. Romano has raised more than $100 million through public and private financings and has extensive experience supporting emerging growth
public companies, including robotic surgery and medical technology organizations, through periods of transformation, growth, and strategic
change.

 

Ms. Romano began her career as an auditor at PricewaterhouseCoopers
and is a licensed Certified Public Accountant (CPA) in Massachusetts. She earned a Bachelor of Arts in Accounting from the College of
the Holy Cross and Master of Accountancy in Accounting from Boston College.

 

About SS Innovations

 

SS Innovations International, Inc. (Nasdaq: SSII)
develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a
larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical
robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic
procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of
its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com
or LinkedIn for more information and updates.

 

  

  

 

 

About the SSi Mantra

 

The SSi Mantra is a user-friendly, modular, multi-arm
system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large
3D 4K monitor, a touch panel monitor for all patient-related information display, a virtual real-time image of the robotic patient side
arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is
a portable, compact alternative to the SSi Mantra’s standard surgeon command center that provides equivalent control functionality
while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types
of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric
population and ENT surgeries. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide
better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 170 different types of surgical procedures.

 

Forward Looking Statements

 

This press release may contain statements that
are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.
The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,”
“intend,” “may,” “plan,” “project,” “should,” “could,” “seek,”
“designed,” “potential,” “forecast,” “target,” “objective,” “goal,”
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that
may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels
of activity, performance or achievements expressed or implied by these forward-looking statements.

 

Investor Contact:

 

The Equity Group

Kalle Ahl, CFA

T: (303) 953-9878

[email protected]

 

Devin Sullivan, Managing Director

T: (212) 836-9608

[email protected]

 

Media Contact:

 

RooneyPartners LLC

Kate Barrette

T: (212) 223-0561

[email protected]